{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:30:07Z","timestamp":1793017807887,"version":"4.5.0"},"reference-count":66,"publisher":"Vilnius University Press","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AML"],"abstract":"<jats:p>Background:\u00a0Lyme disease can lead to neuropsychiatric symptoms like depression, anxiety, and cognitive issues, often mimicking primary psychiatric disorders. This paper examines the connection between Lyme disease and neuropsychiatric outcomes to improve diagnosis and treatment.Materials and Methods:\u00a0The\u00a0PubMed\u00a0database was searched for scientific literature sources. Publications published in English in 2019\u20132024 were selected. All psychiatric symptoms and disorders found to be associated with Lyme disease were included. For neurological symptoms, the analysis focused on studies addressing cognitive dysfunction.Results:\u00a0Acute neuroborreliosis may have minimal effects on the cognitive function and typically resolves well with treatment. However, some studies suggest that Lyme disease can affect the patients\u2019 cognitive abilities, leading to impairments in verbal fluency, attention, and memory, with a few isolated dementia-like cases highlighting the need for careful diagnosis. Nevertheless, recent large-scale studies show no increased risk of dementia. Regarding psychiatric symptoms, findings are also inconsistent, with some studies suggesting an increased risk of depression, anxiety, sleep disturbances, and other mental health conditions, while others find no such association.Conclusions:\u00a0There is no strong evidence supporting Lyme disease\u2019s role in long-term cognitive or psychiatric disorders. However, an early diagnosis and timely antibiotic treatment remain crucial in minimizing long-term consequences and improving patient outcomes.<\/jats:p>","DOI":"10.15388\/amed.2025.32.1.17","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:15:09Z","timestamp":1744762509000},"page":"6-21","source":"Crossref","is-referenced-by-count":2,"title":["Neuropsychiatric Manifestations of Lyme Disease: A Literature Review of Psychiatric and Cognitive Impacts"],"prefix":"10.15388","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0259-6823","authenticated-orcid":false,"given":"Gabija","family":"\u0160eg\u017edait\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6062-9340","authenticated-orcid":false,"given":"Odeta","family":"Aliukonyt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9916-4418","authenticated-orcid":false,"given":"Kamil\u0117","family":"Poci\u016bt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6097","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Paradowska-Stankiewicz I, Zbrzezniak J, Skufca J, Nagarajan A, Ochocka P, Pilz A, et al. A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019: A Public Health Concern. Vector Borne Zoonotic Dis. 2023;23(4):247-55 DOI: 10.1089\/vbz.2022.0049.","DOI":"10.1089\/vbz.2022.0049"},{"key":"ref1","unstructured":"Centers for Disease Control and Prevention. Lyme Disease Data and Statistics May 15, 2024 [updated March 15, 2024; cited 2024 September 2]. Available from: https:\/\/www.cdc.gov\/lyme\/data-research\/facts-stats\/index.html."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Burn L, Vyse A, Pilz A, Tran TMP, Fletcher MA, Angulo FJ, et al. Incidence of Lyme Borreliosis in Europe: A Systematic Review (2005-2020). Vector Borne Zoonotic Dis. 2023;23(4):172-94 DOI: 10.1089\/vbz.2022.0070.","DOI":"10.1089\/vbz.2022.0070"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Cerny J, Lynn G, Hrnkova J, Golovchenko M, Rudenko N, Grubhoffer L. Management Options for Ixodes ricinus-Associated Pathogens: A Review of Prevention Strategies. Int J Environ Res Public Health. 2020;17(6) DOI: 10.3390\/ijerph17061830.","DOI":"10.3390\/ijerph17061830"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Pfaffle M, Littwin N, Muders SV, Petney TN. The ecology of tick-borne diseases. Int J Parasitol. 2013;43(12-13):1059-77 DOI: 10.1016\/j.ijpara.2013.06.009.","DOI":"10.1016\/j.ijpara.2013.06.009"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Porretta D, Mastrantonio V, Amendolia S, Gaiarsa S, Epis S, Genchi C, et al. Effects of global changes on the climatic niche of the tick Ixodes ricinus inferred by species distribution modelling. Parasit Vectors. 2013;6:271 DOI: 10.1186\/1756-3305-6-271.","DOI":"10.1186\/1756-3305-6-271"},{"key":"ref6","unstructured":"Lindgren E, Jaenson TGT. Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures Copenhagen; 2006."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Rayment C, O'Flynn N. Diagnosis and management of patients with Lyme disease: NICE guideline. Br J Gen Pract. 2018;68(676):546-7 DOI: 10.3399\/bjgp18X699713.","DOI":"10.3399\/bjgp18X699713"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Quintero JA, Attah R, Khianey R, Capitle E, Schutzer SE. Arthritis and Diagnostics in Lyme Disease. Trop Med Infect Dis. 2021;6(1) DOI: 10.3390\/tropicalmed6010018.","DOI":"10.3390\/tropicalmed6010018"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Radesich C, Del Mestre E, Medo K, Vitrella G, Manca P, Chiatto M, et al. Lyme Carditis: From Pathophysiology to Clinical Management. Pathogens. 2022;11(5) DOI: 10.3390\/pathogens11050582.","DOI":"10.3390\/pathogens11050582"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Garcia-Monco JC, Benach JL. Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections. Ann Neurol. 2019;85(1):21-31 DOI: 10.1002\/ana.25389.","DOI":"10.1002\/ana.25389"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Coburn J, Garcia B, Hu LT, Jewett MW, Kraiczy P, Norris SJ, et al. Lyme Disease Pathogenesis. Curr Issues Mol Biol. 2021;42:473-518 DOI: 10.21775\/cimb.042.473.","DOI":"10.21775\/cimb.042.473"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Aucott JN. Posttreatment Lyme disease syndrome. Infect Dis Clin North Am. 2015;29(2):309-23 DOI: 10.1016\/j.idc.2015.02.012.","DOI":"10.1016\/j.idc.2015.02.012"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Brackett M, Potts J, Meihofer A, Indorewala Y, Ali A, Lutes S, et al. Neuropsychiatric Manifestations and Cognitive Decline in Patients With Long-Standing Lyme Disease: A Scoping Review. Cureus. 2024;16(4):e58308 DOI: 10.7759\/cureus.58308.","DOI":"10.7759\/cureus.58308"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Andreassen S, Lindland EMS, Solheim AM, Beyer MK, Ljostad U, Mygland A, et al. Cognitive function, fatigue and Fazekas score in patients with acute neuroborreliosis. Ticks Tick Borne Dis. 2021;12(3):101678 DOI: 10.1016\/j.ttbdis.2021.101678.","DOI":"10.1016\/j.ttbdis.2021.101678"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Andreassen S, Lindland EMS, Beyer MK, Solheim AM, Ljostad U, Mygland A, et al. Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis. J Neurol. 2023;270(3):1430-8 DOI: 10.1007\/s00415-022-11463-7.","DOI":"10.1007\/s00415-022-11463-7"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Hundersen F, Forst S, Kasten E. Neuropsychiatric and Psychological Symptoms in Patients with Lyme Disease: A Study of 252 Patients. Healthcare (Basel). 2021;9(6) DOI: 10.3390\/healthcare9060733.","DOI":"10.3390\/healthcare9060733"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Berende A, Agelink van Rentergem J, Evers AWM, Ter Hofstede HJM, Vos FJ, Kullberg BJ, et al. Cognitive impairments in patients with persistent symptoms attributed to Lyme disease. BMC Infect Dis. 2019;19(1):833 DOI: 10.1186\/s12879-019-4452-y.","DOI":"10.1186\/s12879-019-4452-y"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Bransfield RC, Aidlen DM, Cook MJ, Javia S. A Clinical Diagnostic System for Late-Stage Neuropsychiatric Lyme Borreliosis Based upon an Analysis of 100 Patients. Healthcare (Basel). 2020;8(1) DOI: 10.3390\/healthcare8010013.","DOI":"10.3390\/healthcare8010013"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Maxwell SP, Brooks C, McNeely CL, Thomas KC. Neurological Pain, Psychological Symptoms, and Diagnostic Struggles among Patients with Tick-Borne Diseases. Healthcare (Basel). 2022;10(7) DOI: 10.3390\/healthcare10071178.","DOI":"10.3390\/healthcare10071178"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Voitey M, Bouiller K, Chirouze C, Fournier D, Bozon F, Klopfenstein T. Functional signs in patients consulting for presumed Lyme borreliosis. Med Mal Infect. 2020;50(5):423-7 DOI: 10.1016\/j.medmal.2019.10.011.","DOI":"10.1016\/j.medmal.2019.10.011"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Gorlyn M, Keilp JG, Fallon BA. Language Fluency Deficits in Post-treatment Lyme Disease Syndrome. Arch Clin Neuropsychol. 2023;38(4):650-4 DOI: 10.1093\/arclin\/acac095.","DOI":"10.1093\/arclin\/acac095"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Geebelen L, Lernout T, Devleesschauwer B, Kabamba-Mukadi B, Saegeman V, Belkhir L, et al. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020). BMC Infect Dis. 2022;22(1):756 DOI: 10.1186\/s12879-022-07686-8.","DOI":"10.1186\/s12879-022-07686-8"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Marvel CL, Alm KH, Bhattacharya D, Rebman AW, Bakker A, Morgan OP, et al. A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease. PLoS One. 2022;17(10):e0271425 DOI: 10.1371\/journal.pone.0271425.","DOI":"10.1371\/journal.pone.0271425"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Andreassen S, Solheim AM, Ljostad U, Mygland A, Lorentzen AR, Reiso H, et al. Cognitive function in patients with neuroborreliosis: A prospective cohort study from the acute phase to 12 months post treatment. Brain Behav. 2022;12(6):e2608 DOI: 10.1002\/brb3.2608.","DOI":"10.1002\/brb3.2608"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Senejani AG, Maghsoudlou J, El-Zohiry D, Gaur G, Wawrzeniak K, Caravaglia C, et al. Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues. J Alzheimers Dis. 2022;85(2):889-903 DOI: 10.3233\/JAD-215398.","DOI":"10.3233\/JAD-215398"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Gadila SKG, Rosoklija G, Dwork AJ, Fallon BA, Embers ME. Detecting Borrelia Spirochetes: A Case Study With Validation Among Autopsy Specimens. Front Neurol. 2021;12:628045 DOI: 10.3389\/fneur.2021.628045.","DOI":"10.3389\/fneur.2021.628045"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Haahr R, Tetens MM, Dessau RB, Krogfelt KA, Bodilsen J, Andersen NS, et al. Risk of Neurological Disorders in Patients With European Lyme Neuroborreliosis: A Nationwide, Population-Based Cohort Study. Clin Infect Dis. 2020;71(6):1511-6 DOI: 10.1093\/cid\/ciz997.","DOI":"10.1093\/cid\/ciz997"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Sanchini C, Papia C, Cutaia C, Poloni TE, Cesari M. A Case of Reversible Dementia? Dementia vs Delirium in Lyme Disease. Ann Geriatr Med Res. 2023;27(1):80-2 DOI: 10.4235\/agmr.22.0128.","DOI":"10.4235\/agmr.22.0128"},{"key":"ref29","unstructured":"Vargas SE, McCarthy M, Boudreau M, Canfield D, Reece R, Flanigan T. Characterizing the Symptoms of Patients with Persistent Post-Treatment Lyme Symptoms: A Survey of Patients at a Lyme Disease Clinic in Rhode Island. R I Med J (2013). 2021;104(3):53-7."},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Maxwell SP. The Elusive Understanding of Lyme Disease in Non-Endemic Geographic Areas: An Exploratory Survey of Patients With Chronic Symptoms in Texas. J Patient Exp. 2020;7(6):1621-6 DOI: 10.1177\/2374373520926821.","DOI":"10.1177\/2374373520926821"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Bransfield RC, Goud Gadila SK, Kursawe LJ, Dwork AJ, Rosoklija G, Horn EJ, et al. Late-stage borreliosis and substance abuse. Heliyon. 2024;10(10):e31159 DOI: 10.1016\/j.heliyon.2024.e31159.","DOI":"10.1016\/j.heliyon.2024.e31159"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Fallon BA, Madsen T, Erlangsen A, Benros ME. Lyme Borreliosis and Associations With Mental Disorders and Suicidal Behavior: A Nationwide Danish Cohort Study. Am J Psychiatry. 2021;178(10):921-31 DOI: 10.1176\/appi.ajp.2021.20091347.","DOI":"10.1176\/appi.ajp.2021.20091347"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Rozic M, Lah LL, Ruzic-Sabljic E, Kastrin A, Arnez M. Lyme Neuroborreliosis in Children: Etiology and Comparison of Clinical Findings of Lyme Neuroborreliosis Caused by Borrelia garinii and Borrelia afzelii. Pediatr Infect Dis J. 2019;38(11):e279-e84 DOI: 10.1097\/INF.0000000000002415.","DOI":"10.1097\/INF.0000000000002415"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Tetens MM, Graham EE, Andersen NS, Bangsborg J, Bodilsen J, Dessau RB, et al. No associations between neuroborreliosis in children and psychiatric neurodevelopmental disorders: a nationwide, population-based, matched cohort study. J Child Psychol Psychiatry. 2024 DOI: 10.1111\/jcpp.14079.","DOI":"10.1111\/jcpp.14079"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Tetens MM, Haahr R, Dessau RB, Krogfelt KA, Bodilsen J, Andersen NS, et al. Assessment of the Risk of Psychiatric Disorders, Use of Psychiatric Hospitals, and Receipt of Psychiatric Medication Among Patients With Lyme Neuroborreliosis in Denmark. JAMA Psychiatry. 2021;78(2):177-86 DOI: 10.1001\/jamapsychiatry.2020.2915.","DOI":"10.1001\/jamapsychiatry.2020.2915"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Redolfi A, Rota V, Tirloni C, Buraschi R, Arienti C, Falso MV. Retrograde and semantic amnesia in a case of post-treatment Lyme disease syndrome: did something lead to a psychogenic memory loss? A single-case study. Neurocase. 2024;30(3):97-105 DOI: 10.1080\/13554794.2024.2371906.","DOI":"10.1080\/13554794.2024.2371906"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Cunha F, Duarte JA, Goncalves R. Acute Lyme neuroborreliosis with transient aphasia - Case report and review of current knowledge. IDCases. 2022;27:e01443 DOI: 10.1016\/j.idcr.2022.e01443.","DOI":"10.1016\/j.idcr.2022.e01443"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Vieira JP, Brito MJ, de Carvalho IL. Borrelia lusitaniae Infection Mimicking Headache, Neurologic Deficits, and Cerebrospinal Fluid Lymphocytosis. J Child Neurol. 2019;34(12):748-50 DOI: 10.1177\/0883073819858263.","DOI":"10.1177\/0883073819858263"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Gimsing LN, Hejl AM. Normal pressure hydrocephalus secondary to Lyme disease, a case report and review of seven reported cases. BMC Neurol. 2020;20(1):347 DOI: 10.1186\/s12883-020-01917-8.","DOI":"10.1186\/s12883-020-01917-8"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Pauwels EKJ, Boer GJ. Friends and Foes in Alzheimer's Disease. Med Princ Pract. 2023;32(6):313-22 DOI: 10.1159\/000534400.","DOI":"10.1159\/000534400"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Miklossy J. Chronic inflammation and amyloidogenesis in Alzheimer's disease -- role of Spirochetes. J Alzheimers Dis. 2008;13(4):381-91 DOI: 10.3233\/jad-2008-13404.","DOI":"10.3233\/JAD-2008-13404"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Bashchobanov DH, Stamatova E, Andonova R, Dragusheva E, Gadzhovska V, Popov G. Lyme Neuroborreliosis in the Context of Dementia Syndromes. Cureus. 2024;16(8):e67057 DOI: 10.7759\/cureus.67057.","DOI":"10.7759\/cureus.67057"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Kristoferitsch W, Aboulenein-Djamshidian F, Jecel J, Rauschka H, Rainer M, Stanek G, et al. Secondary dementia due to Lyme neuroborreliosis. Wien Klin Wochenschr. 2018;130(15-16):468-78 DOI: 10.1007\/s00508-018-1361-9.","DOI":"10.1007\/s00508-018-1361-9"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Khatchikian CE, Nadelman RB, Nowakowski J, Schwartz I, Wormser GP, Brisson D. Evidence for strain-specific immunity in patients treated for early lyme disease. Infect Immun. 2014;82(4):1408-13 DOI: 10.1128\/IAI.01451-13.","DOI":"10.1128\/IAI.01451-13"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014;71(10):1121-8 DOI: 10.1001\/jamapsychiatry.2014.1332.","DOI":"10.1001\/jamapsychiatry.2014.1332"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Severance EG, Yolken RH, Eaton WW. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res. 2016;176(1):23-35 DOI: 10.1016\/j.schres.2014.06.027.","DOI":"10.1016\/j.schres.2014.06.027"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Rebman AW, Aucott JN. Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease. Front Med (Lausanne). 2020;7:57 DOI: 10.3389\/fmed.2020.00057.","DOI":"10.3389\/fmed.2020.00057"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Kohler-Forsberg O, Petersen L, Gasse C, Mortensen PB, Dalsgaard S, Yolken RH, et al. A Nationwide Study in Denmark of the Association Between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents. JAMA Psychiatry. 2019;76(3):271-9 DOI: 10.1001\/jamapsychiatry.2018.3428.","DOI":"10.1001\/jamapsychiatry.2018.3428"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry. 2011;168(12):1303-10 DOI: 10.1176\/appi.ajp.2011.11030516.","DOI":"10.1176\/appi.ajp.2011.11030516"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Nemeth J, Bernasconi E, Heininger U, Abbas M, Nadal D, Strahm C, et al. Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss Med Wkly. 2016;146:w14353 DOI: 10.4414\/smw.2016.14353.","DOI":"10.4414\/smw.2016.14353"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Bai NA, Richardson CS. Posttreatment Lyme disease syndrome and myalgic encephalomyelitis\/chronic fatigue syndrome: A systematic review and comparison of pathogenesis. Chronic Dis Transl Med. 2023;9(3):183-90 DOI: 10.1002\/cdt3.74.","DOI":"10.1002\/cdt3.74"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019;26(1):27-40 DOI: 10.1111\/ene.13819.","DOI":"10.1111\/ene.13819"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Garkowski A, Lebkowska U, Kubas B, Garkowska E, Rutka K, Gawarecka E, et al. Imaging of Lyme Neuroborreliosis: A Pictorial Review. Open Forum Infect Dis. 2020;7(10):ofaa370 DOI: 10.1093\/ofid\/ofaa370.","DOI":"10.1093\/ofid\/ofaa370"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Ford H. Clinical presentation and diagnosis of multiple sclerosis. Clin Med (Lond). 2020;20(4):380-3 DOI: 10.7861\/clinmed.2020-0292.","DOI":"10.7861\/clinmed.2020-0292"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Branda JA, Steere AC. Laboratory Diagnosis of Lyme Borreliosis. Clin Microbiol Rev. 2021;34(2) DOI: 10.1128\/CMR.00018-19.","DOI":"10.1128\/CMR.00018-19"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Ranque-Garnier S, Eldin C, Sault C, Raoult D, Donnet A. Management of patients presenting with generalized musculoskeletal pain and a suspicion of Lyme disease. Med Mal Infect. 2019;49(2):157-66 DOI: 10.1016\/j.medmal.2019.01.008.","DOI":"10.1016\/j.medmal.2019.01.008"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Steere AC. Musculoskeletal manifestations of Lyme disease. Am J Med. 1995;98(4A):44S-8S; discussion 8S-51S DOI: 10.1016\/s0002-9343(99)80043-6.","DOI":"10.1016\/S0002-9343(99)80043-6"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Gaudino EA, Coyle PK, Krupp LB. Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences. Arch Neurol. 1997;54(11):1372-6 DOI: 10.1001\/archneur.1997.00550230045015.","DOI":"10.1001\/archneur.1997.00550230045015"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Dersch R, Torbahn G, Rauer S. Treatment of post-treatment Lyme disease symptoms-a systematic review. Eur J Neurol. 2024;31(7):e16293 DOI: 10.1111\/ene.16293.","DOI":"10.1111\/ene.16293"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Yehudina Y, Trypilka S. Lyme Borreliosis as a Trigger for Autoimmune Disease. Cureus. 2021;13(10):e18648 DOI: 10.7759\/cureus.18648.","DOI":"10.7759\/cureus.18648"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Sebastien P, Jacques D, Catherine P, Xavier G. Diagnosis and treatment of \"chronic Lyme\": primum non nocere. BMC Infect Dis. 2023;23(1):642 DOI: 10.1186\/s12879-023-08618-w.","DOI":"10.1186\/s12879-023-08618-w"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Wong KH, Shapiro ED, Soffer GK. A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist. Clin Rev Allergy Immunol. 2022;62(1):264-71 DOI: 10.1007\/s12016-021-08906-w.","DOI":"10.1007\/s12016-021-08906-w"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Hassett AL, Radvanski DC, Buyske S, Savage SV, Sigal LH. Psychiatric comorbidity and other psychological factors in patients with \"chronic Lyme disease\". Am J Med. 2009;122(9):843-50 DOI: 10.1016\/j.amjmed.2009.02.022.","DOI":"10.1016\/j.amjmed.2009.02.022"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Schneider RK, Robinson MJ, Levenson JL. Psychiatric presentations of non-HIV infectious diseases. Neurocysticercosis, Lyme disease, and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection. Psychiatr Clin North Am. 2002;25(1):1-16 DOI: 10.1016\/s0193-953x(03)00049-2.","DOI":"10.1016\/S0193-953X(03)00049-2"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Zhang X, Jiang Y, Chen Y, Yang J, Zhang X, Xing L, et al. Efficacy and safety of antibiotic therapy for post-Lyme disease? A systematic review and network meta-analysis. BMC Infect Dis. 2023;23(1):22 DOI: 10.1186\/s12879-023-07989-4.","DOI":"10.1186\/s12879-023-07989-4"}],"container-title":["Acta medica Lituanica"],"original-title":[],"link":[{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/download\/38092\/38526","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/download\/38092\/38527","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/download\/38092\/38527","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/download\/38092\/38526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T12:04:41Z","timestamp":1753704281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journals.vu.lt\/AML\/article\/view\/38092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.15388\/amed.2025.32.1.17","relation":{},"ISSN":["2029-4174","1392-0138"],"issn-type":[{"value":"2029-4174","type":"electronic"},{"value":"1392-0138","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}